Safety and efficacy of tisagenlecleucel plus pembrolizumab in patients with r/r DLBCL: phase 1b PORTIA study results
暂无分享,去创建一个
P. Riedell | U. Jaeger | Xia Han | E. Waller | I. Fleury | N. Worel | David Pearson | Yan Du | J. Mcguirk | S. Redondo
暂无分享,去创建一个
P. Riedell | U. Jaeger | Xia Han | E. Waller | I. Fleury | N. Worel | David Pearson | Yan Du | J. Mcguirk | S. Redondo